Liu Z et al. |
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice. |
2015 |
Sci Rep |
pmid:25830356
|
Di Marzo V |
Endocannabinoids: synthesis and degradation. |
2008 |
Rev. Physiol. Biochem. Pharmacol. |
pmid:18481028
|
Strewe C et al. |
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans. |
2012 |
Rev Neurosci |
pmid:23023882
|
Hauer D et al. |
Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression. |
2012 |
Rev Neurosci |
pmid:23006898
|
Costa MA et al. |
2-arachidonoylglycerol effects in cytotrophoblasts: metabolic enzymes expression and apoptosis in BeWo cells. |
2014 |
Reproduction |
pmid:24324206
|
Brosnihan KB et al. |
Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats. |
2015 |
Reprod. Biol. Endocrinol. |
pmid:25596750
|
Sanchez AM et al. |
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis. |
2016 |
Reprod Sci |
pmid:26887427
|
Scotchie JG et al. |
Endocannabinoid regulation in human endometrium across the menstrual cycle. |
2015 |
Reprod Sci |
pmid:24819878
|
Wang F et al. |
2-Arachidonylglycerol Protects Primary Astrocytes Exposed to Oxygen-Glucose Deprivation Through a Blockade of NDRG2 Signaling and STAT3 Phosphorylation. |
2016 |
Rejuvenation Res |
pmid:26414218
|
Qi M et al. |
A robust capillary liquid chromatography/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids. |
2015 |
Rapid Commun. Mass Spectrom. |
pmid:26411510
|
Higgs S et al. |
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. |
2003 |
Psychopharmacology (Berl.) |
pmid:12447606
|
Sustkova-Fiserova M et al. |
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens. |
2016 |
Psychopharmacology (Berl.) |
pmid:26507196
|
Llorente-Berzal A et al. |
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. |
2015 |
Psychopharmacology (Berl.) |
pmid:25814137
|
Aliczki M et al. |
Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice. |
2015 |
Psychopharmacology (Berl.) |
pmid:25547462
|
Limebeer CL et al. |
Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system. |
2014 |
Psychopharmacology (Berl.) |
pmid:24043345
|
McReynolds JR et al. |
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats. |
2016 |
Psychopharmacology (Berl.) |
pmid:26455361
|
Coccaro EF et al. |
Circulating endocannabinoids and affect regulation in human subjects. |
2018 |
Psychoneuroendocrinology |
pmid:29627714
|
Heyman E et al. |
Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. |
2012 |
Psychoneuroendocrinology |
pmid:22029953
|
Atsak P et al. |
Glucocorticoid-endocannabinoid uncoupling mediates fear suppression deficits after early - Life stress. |
2018 |
Psychoneuroendocrinology |
pmid:29524763
|
Hill MN et al. |
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. |
2009 |
Psychoneuroendocrinology |
pmid:19394765
|
Gray JM et al. |
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. |
2016 |
Psychoneuroendocrinology |
pmid:26821211
|
Hill MN et al. |
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. |
2013 |
Psychoneuroendocrinology |
pmid:24035186
|
Schalk-Hihi C et al. |
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Ã… resolution. |
2011 |
Protein Sci. |
pmid:21308848
|
Basavarajappa BS |
Critical enzymes involved in endocannabinoid metabolism. |
2007 |
Protein Pept. Lett. |
pmid:17346227
|
Biernacki M et al. |
Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma. |
2018 |
Prostaglandins Other Lipid Mediat. |
pmid:30201316
|
Wang J and Ueda N |
Biology of endocannabinoid synthesis system. |
2009 |
Prostaglandins Other Lipid Mediat. |
pmid:19126434
|
Wang H et al. |
Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. |
2007 |
Prostaglandins Other Lipid Mediat. |
pmid:17259073
|
Fonseca BM et al. |
Endogenous cannabinoids revisited: a biochemistry perspective. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23474290
|
Hillard CJ |
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785538
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives in cancer and inflammation. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785541
|
Kunos G et al. |
Cardiovascular effects of endocannabinoids--the plot thickens. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785543
|
Szafran B et al. |
Lipopolysaccharide suppresses carboxylesterase 2g activity and 2-arachidonoylglycerol hydrolysis: A possible mechanism to regulate inflammation. |
2015 |
Prostaglandins Other Lipid Mediat. |
pmid:26403860
|
Avraham Y et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. |
2008 Jul-Aug |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:18771906
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Watanabe S et al. |
n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12878451
|
Matias I et al. |
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. |
2006 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:17011761
|
Iannotti FA et al. |
Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats. |
2013 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:23830028
|
Yi B et al. |
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors. |
2016 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:26780604
|
Bystrowska B et al. |
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. |
2014 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:24334211
|
Gould GG et al. |
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. |
2012 |
Prog. Neuropsychopharmacol. Biol. Psychiatry |
pmid:22542870
|
Baggelaar MP et al. |
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. |
2018 |
Prog. Lipid Res. |
pmid:29751000
|
Iannotti FA et al. |
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. |
2016 |
Prog. Lipid Res. |
pmid:26965148
|
Sugiura T et al. |
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2006 |
Prog. Lipid Res. |
pmid:16678907
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Grimaldi P et al. |
The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis. |
2009 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:19541620
|
Tanimura A et al. |
Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. |
2012 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22783023
|
Ruby MA et al. |
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. |
2008 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18794527
|
Mitchener MM et al. |
Competition and allostery govern substrate selectivity of cyclooxygenase-2. |
2015 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:26392530
|